NasdaqCM - Nasdaq Real Time Price USD
Outlook Therapeutics, Inc. (OTLK)
1.8700
-0.0400
(-2.09%)
At close: 4:00:01 PM EDT
1.8300
-0.04
(-2.14%)
After hours: 5:43:28 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.47 | -0.32 | -2.08 | -1.29 |
| Low Estimate | -0.58 | -0.51 | -2.52 | -1.77 |
| High Estimate | -0.33 | -0.13 | -1.4 | -0.95 |
| Year Ago EPS | -0.83 | -0.94 | -3.99 | -2.08 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 5 |
| Avg. Estimate | 1.91M | 6.76M | 7.28M | 34.93M |
| Low Estimate | -- | 4M | 1.7M | 17.1M |
| High Estimate | 4.5M | 8.7M | 12.57M | 50.95M |
| Year Ago Sales | -- | -- | -- | 7.28M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 379.84% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.84 | -0.82 | -0.75 | -0.55 |
| EPS Actual | -0.83 | -0.94 | -0.89 | -0.34 |
| Difference | 0.01 | -0.12 | -0.14 | 0.22 |
| Surprise % | 1.73% | -14.26% | -17.88% | 39.19% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.47 | -0.32 | -2.08 | -1.29 |
| 7 Days Ago | -0.49 | -0.38 | -2.13 | -1.29 |
| 30 Days Ago | -0.49 | -0.38 | -2.13 | -1.29 |
| 60 Days Ago | -0.57 | -0.44 | -2.62 | -1.29 |
| 90 Days Ago | -0.57 | -0.44 | -2.62 | -1.05 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OTLK | 42.66% | 65.84% | 47.82% | 37.92% |
| S&P 500 | 13.12% | 2.46% | 7.55% | 13.98% |
Upgrades & Downgrades
| Maintains | Ascendiant Capital: Buy to Buy | 2/24/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/18/2025 |
| Maintains | Chardan Capital: Neutral to Neutral | 2/18/2025 |
| Reiterates | Guggenheim: Buy to Buy | 1/17/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/17/2025 |
| Downgrade | Chardan Capital: Buy to Neutral | 12/2/2024 |
Related Tickers
PYPD PolyPid Ltd.
3.1600
+6.04%
UNCY Unicycive Therapeutics, Inc.
0.7692
-0.75%
ABEO Abeona Therapeutics Inc.
6.48
+0.62%
KALV KalVista Pharmaceuticals, Inc.
13.80
+1.92%
APLT Applied Therapeutics, Inc.
0.3638
-3.09%
ALXO ALX Oncology Holdings Inc.
0.5250
-1.70%
PDSB PDS Biotechnology Corporation
1.5600
-5.45%
CKPT Checkpoint Therapeutics, Inc.
4.2600
+0.71%
DRMA Dermata Therapeutics, Inc.
0.7040
-0.56%
GOSS Gossamer Bio, Inc.
1.2600
0.00%